240 related articles for article (PubMed ID: 33077835)
1. Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma.
Angel I; Pilo Kerman O; Rousso-Noori L; Friedmann-Morvinski D
Oncogene; 2020 Nov; 39(46):6990-7004. PubMed ID: 33077835
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
3. lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma.
Tang G; Luo L; Zhang J; Zhai D; Huang D; Yin J; Zhou Q; Zhang Q; Zheng G
Cancer Lett; 2021 Feb; 498():152-164. PubMed ID: 33130316
[TBL] [Abstract][Full Text] [Related]
4. NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma.
Song Y; Jiang Y; Tao D; Wang Z; Wang R; Wang M; Han S
Neuro Oncol; 2020 Jan; 22(1):46-57. PubMed ID: 31400279
[TBL] [Abstract][Full Text] [Related]
5. Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.
Sarkar S; Mirzaei R; Zemp FJ; Wei W; Senger DL; Robbins SM; Yong VW
Cancer Res; 2017 Jun; 77(12):3231-3243. PubMed ID: 28416488
[TBL] [Abstract][Full Text] [Related]
6. Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB.
Tchoghandjian A; Jennewein C; Eckhardt I; Momma S; Figarella-Branger D; Fulda S
Cell Death Differ; 2014 May; 21(5):735-47. PubMed ID: 24488095
[TBL] [Abstract][Full Text] [Related]
7. ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.
Sarkar S; Zemp FJ; Senger D; Robbins SM; Yong VW
Neuro Oncol; 2015 Aug; 17(8):1095-105. PubMed ID: 25646025
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.
Ma D; Liu S; Lal B; Wei S; Wang S; Zhan D; Zhang H; Lee RS; Gao P; Lopez-Bertoni H; Ying M; Li JJ; Laterra J; Wilson MA; Xia S
Cancer Res; 2019 May; 79(10):2697-2708. PubMed ID: 30898840
[TBL] [Abstract][Full Text] [Related]
9. IL-33/ST2 axis promotes glioblastoma cell invasion by accumulating tenascin-C.
Zhang JF; Tao T; Wang K; Zhang GX; Yan Y; Lin HR; Li Y; Guan MW; Yu JJ; Wang XD
Sci Rep; 2019 Dec; 9(1):20276. PubMed ID: 31889095
[TBL] [Abstract][Full Text] [Related]
10. Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays.
Nie S; Gurrea M; Zhu J; Thakolwiboon S; Heth JA; Muraszko KM; Fan X; Lubman DM
J Proteome Res; 2015 Feb; 14(2):814-22. PubMed ID: 25469866
[TBL] [Abstract][Full Text] [Related]
11. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
Kim SH; Ezhilarasan R; Phillips E; Gallego-Perez D; Sparks A; Taylor D; Ladner K; Furuta T; Sabit H; Chhipa R; Cho JH; Mohyeldin A; Beck S; Kurozumi K; Kuroiwa T; Iwata R; Asai A; Kim J; Sulman EP; Cheng SY; Lee LJ; Nakada M; Guttridge D; DasGupta B; Goidts V; Bhat KP; Nakano I
Cancer Cell; 2016 Feb; 29(2):201-13. PubMed ID: 26859459
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB
Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668
[TBL] [Abstract][Full Text] [Related]
13. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.
Berezovsky AD; Poisson LM; Cherba D; Webb CP; Transou AD; Lemke NW; Hong X; Hasselbach LA; Irtenkauf SM; Mikkelsen T; deCarvalho AC
Neoplasia; 2014 Mar; 16(3):193-206, 206.e19-25. PubMed ID: 24726753
[TBL] [Abstract][Full Text] [Related]
14. Plasticity in Glioma Stem Cell Phenotype and Its Therapeutic Implication.
Iwadate Y
Neurol Med Chir (Tokyo); 2018 Feb; 58(2):61-70. PubMed ID: 29129882
[TBL] [Abstract][Full Text] [Related]
15. Silencing LncRNA LOXL1-AS1 attenuates mesenchymal characteristics of glioblastoma via NF-κB pathway.
Wang H; Li L; Yin L
Biochem Biophys Res Commun; 2018 Jun; 500(2):518-524. PubMed ID: 29678575
[TBL] [Abstract][Full Text] [Related]
16. FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
Cheng P; Wang J; Waghmare I; Sartini S; Coviello V; Zhang Z; Kim SH; Mohyeldin A; Pavlyukov MS; Minata M; Valentim CL; Chhipa RR; Bhat KP; Dasgupta B; La Motta C; Kango-Singh M; Nakano I
Cancer Res; 2016 Dec; 76(24):7219-7230. PubMed ID: 27569208
[TBL] [Abstract][Full Text] [Related]
17. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
18. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
[TBL] [Abstract][Full Text] [Related]
19. Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males.
Sun T; Warrington NM; Luo J; Brooks MD; Dahiya S; Snyder SC; Sengupta R; Rubin JB
J Clin Invest; 2014 Sep; 124(9):4123-33. PubMed ID: 25083989
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells.
Zhu TS; Costello MA; Talsma CE; Flack CG; Crowley JG; Hamm LL; He X; Hervey-Jumper SL; Heth JA; Muraszko KM; DiMeco F; Vescovi AL; Fan X
Cancer Res; 2011 Sep; 71(18):6061-72. PubMed ID: 21788346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]